Galderma Gets Competition Approvals to Buy Q-Med
From M&A Navigator (February 11, 2011)
Swiss pharmaceutical company Galderma Pharma said on Friday it had
won all regulatory approvals for its bid to buy Swedish biotech
firm Q-Med AB (STO:QMED), except for the one in Cyprus which it
expects to get soon.
Galderma, a L’Oreal (EPA:OR) and Nestle (VTX:NESN) joint venture, raised on Thursday its offer for Q-Med to SEK79 (USD12.09/EUR8.94) per share from SEK75, valuing the company at SEK7.9bn.
Q-Med shareholders owning 78% in the company have already pledged acceptance to Galderma¢?¬s offer, the buyer said.
Country: , Sweden
Sector: Biotechnology
Target: Q-Med AB
Buyer: Galderma Pharma SA
Deal size in USD: 1.2bn
Type: Corporate acquisition
Status: Bidding
Comment: Galderma gets regulatory clearance, except for Cyprus.
((Comments on this story may be sent to info@m2.com))
Posted: February 2011
